Sudden unexpected death in epilepsy patients SUDEP EEG suppression PGES A B S T R A C T Purpose: Our objective was to determine the significance of PGES as a possible EEG marker of increased risk for SUDEP and explore factors that influence PGES. Methods: We identified 17 patients who died due to definite or probable SUDEP and 52 living control patients with drug resistant focal epilepsy who underwent EEG monitoring and least one seizure recorded on EEG. We reviewed 305 seizures on EEG and when available, on video, for presence or absence of PGES, the duration of PGES immediately after seizure end, seizure type, state seizure occurred (sleep vs. wake), tonic duration and time from seizure onset to initial nursing intervention. We noted that majority (93% in SUDEP group and 83% living controls) with PGES had additional brief bursts of suppression. We measured the time from the end of seizure to end of last brief suppression to determine the time to final PGES. Results: SUDEP patients had statistically significant shorter PGES duration compared to living controls (unadjusted: À32.8 s, 95%CI[À54.5, À11.2], adjusted: À39.5 s, 95% CI[À59.4, À19.6]). SUDEP status was associated with longer time to final PGES compare to living controls, but this was not statistically significant. Earlier nursing intervention was associated with shorter seizure duration. PGES occurred only after GCS. Time to nursing intervention, tonic duration or state did not have a statistically significant effect on PGES. Conclusions: PGES is an equivocal marker of increased SUDEP risk. Earlier nursing intervention is associated with shorter seizure duration and may play a role in reducing risk of SUDEP.
Introduction
Sudden unexpected death in epilepsy (SUDEP) is one of the major causes of epilepsy-related death [1] [2] [3] . The incidence of SUDEP in the general epilepsy population is significant; the estimated mortality rate ranges from 0.13-2.7 per 1000 personyears and is significantly higher in patients with drug resistant epilepsy (3.5-9.3/1000 person-years) [4] . The risk is increased as the severity of seizures increase and accumulates with each year that passes with uncontrolled seizures [5, 6] .
There has been significant effort in the past decade to understand the pathogenesis and prevent SUDEP. Several case reports and studies analyzed the cardiovascular, respiratory, and EEG recordings around the time of SUDEP occurring in the epilepsy monitoring unit to (EMU) to shed light on the pathophysiology and biomarkers of SUDEP [7] . A potential physiologic biomarker of SUDEP susceptibility is post-ictal generalized electroencephalogram suppression (PGES), which occurs after 40-66% generalized convulsive seizures in adults [8] . There is good evidence that SUDEP is a seizure-related event; there is often evidence of a witnessed terminal generalized seizure that precedes respiratory or cardiovascular compromise. The MORTality in Epilepsy Monitoring Unit Study (MORTEMUS) reported the following pattern of terminal events seen in 11 adult patients with SUDEP: rapid breathing and varied heart rate, followed by post ictal generalized EEG suppression (PGES), terminal apnea, and finally cardiac arrest [7] . SUDEP also tend to occur during times of lack of supervision and prompt intervention (within 3 min) successful reversed cardiorespiratory arrest in near-SUDEP patients in MORTEMUS. The prevailing thought is that PGES may be a marker of profound, general cortical inhibition which could result in central autonomic depression, resulting in SUDEP [8] . In a landmark case-cohort study, Lhatoo and colleagues [9] demonstrated that the duration of PGES is significantly longer in patients who later died of SUDEP compared to living controls [9] . The odds of dying from SUDEP increased proportionally with PGES duration: for each 1-second increase in duration of PGES, the odds of SUDEP increased by factor of 1.7% (p < 0.005). Lhatoo et al. [9] concluded that PGES (>50 s) appears to identify patients with drug resistant epilepsy at risk of SUDEP. However, a subsequent case-cohort study conducted in a similar fashion did not demonstrate this association between SUDEP and PGES [10] . PGES occurred significantly more frequently after secondarily generalized seizures, but the duration of PGES did not differ between the SUDEP cohort compared to living controls and was an inconsistent finding in patients with several seizures [10, 12] . Thus far, the evidence for PGES as marker of SUDEP in adults is preliminary at best, limited to primarily two retrospective studies [9, 10] with conflicting results.
The objective of this study was to clarify the role of PGES as a marker of increased SUDEP risk from EEG data collected from a cohort of patients who died from probable or definite SUDEP and living controls from Thomas Jefferson University Hospital who underwent EEG monitoring. We noted in majority of cases in our review, there were brief periods of suppression that surpassed the end of the initial PGES. We therefore devised a second time point for PGES, which we called " final PGES", defined as the time from seizure end to the end of the last epoch of bilateral EEG suppression ( 10 uV), occurring after initial PGES, lasting longer than one second and allowing for muscle, movement, breathing and electrode artifact. Lastly, we explored factors influencing PGES duration such as the role of nursing intervention.
Methods
We identified a cohort of patients who died due to definite or probable SUDEP who had prior video-EEG monitoring of their seizures between 1992 to 2014 and had at least one seizure recorded on EEG at Thomas Jefferson University Hospital. Patients with refractory epilepsy were admitted to the epilepsy monitoring unit (EMU) as part of their evaluations for epilepsy surgery. We used the definition of sudden unexpected death in epilepsy patient (SUDEP) utilized by Nashef in 1997 which is a sudden, unexpected, witnessed or unwitnessed, non-traumatic, and non-drowning death in patients with epilepsy, with or without evidence for a seizure, and excluding documented status epilepticus, in which postmortem examination did not reveal a structural or toxicological cause of death [11] . Patients who had autopsy-confirmed SUDEP were considered definite SUDEP cases. Those patients who met all the criteria for SUDEP but did not have post-mortem examinations were considered to be probable SUDEP cases. For controls patients, we chose consecutive, currently living adult patients with drug resistant focal epilepsy who had video EEG monitoring between 2010 to 2015 and had at least 1 or more seizures during monitoring.
For each patient, we reviewed all medical records for information regarding sex, age at follow up/death, MRI finding, seizure type and duration of follow up. Duration of follow-up was defined as time from EMU monitoring to 1) date of death for SUDEP patients, and to 2) date of the current data review for living controls.
When reviewing the EEG for our SUDEP and control patients, we utilized the original definition for PGES as outlined by Lhatoo et al. as immediate (within 30 s), generalized absence of electroencephalographic activity > 10 uV in amplitude, allowing for muscle, movement, breathing and electrode artifacts [9] (See Fig. 1 ). We noted during our review of EEGs that there were several cases where diffuse slowing following end of PGES were punctuated by additional periods of brief suppression. We therefore devised a second time point for PGES, which we called "final PGES", defined as the time from seizure end to the end of the last epoch of bilateral EEG suppression (absence of EEG activity > 10 uV), occurring after initial PGES, lasting longer than one second and allowing for muscle, movement, breathing and electrode artifact (see Fig. 2 ). For each control and case control patient, we reviewed all seizures on EEG for presence or absence of PGES, the duration of PGES immediately after seizure end, time to last PGES, total seizure duration, and tonic phase duration. When video EEG was not available, there were frequent notations by the EEG technicians on the EEG tracing noting behavior of the patient throughout each ictal and post-ictal recording. These notations, in addition to specific EEG findings (including presence of absence of a believable potential fields for each waveform, morphology and frequency of the waveforms, and the presence or absence of obvious movement and muscle artifact) helped the reviewers in assessing each EEG for the presence and duration of PGES. Two board certified clinical neurophysiologists (MN, JK) reviewed the EEG independently for the presence or absence of PGES and, if present, measured the duration of post-generalized EEG suppression (PGES) in seconds. All discrepancies over the presence and duration of PGES were reviewed together until a consensus was achieved. Inter-rater reliability for the presence or absence of PGES was 98%, and for duration difference !5 s was 97%. EEG was reviewed on Nihon Koden System (EEG Version: 08-04) for digital EEG and Grass for paper EEG. EEG recording were performed using conventional scalp EEG recording (International 10-20) system at a sampling rate of 200 Hz (for the digital EEG).
For patients with generalized convulsive seizures (GCS), we reviewed the video and EEG data to measure time from seizure onset to initial intervention (i.e. tactile stimulation, suction, supportive oxygen), PGES lasting more than 50 s, seizure type and duration, and duration of tonic phase. There was no video to review for nursing intervention in the patients in the SUDEP group.
Statistical analysis
Statistical analysis was performed using R (https://www.rproject.org/) and GraphPad Prism version 6.00 for Windows, GraphPad Software, La Jolla California USA, www.graphpad.com.
Differences in PGES duration and in follow up period between the case and control groups were assessed using the MannWhitney test. Categorical data (presence or absence of PGES) were analyzed with Fisher's exact test. We looked at the effect of variables believed to influence PGES duration using unadjusted and adjusted linear mixed models. We also looked at the effect of time to nursing intervention on total seizure duration using linear mixed models.
Results
Data was collected from 5 definite and 12 probable SUDEP patients and 52 living control patients with drug resistant focal epilepsy (see Table 1 ). About a third of patients in the SUDEP group and living controls had lesion positive brain MRI. Median follow up was approximately three times longer in living control patients (1325 days AE 492) than in SUDEP patients (423 days AE 590 days) (Mann-Whitney p = 0.02).
We reviewed a total of 305 electrographic seizures, which included 77 seizures (30 non-convulsive (NCS) and 47 GCS) from the confirmed and probable SUDEP group, and 228 total seizures (142 NCS, 86 GCS) from living control patients. The average number of seizures per patient between the two groups did not differ significantly (4.5 seizures/patient in the SUDEP vs. 4.4 seizures/ patient in the living controls, Mann-Whitney p = 0.89). Fourteen patients (82%) in the SUDEP group and 31 patients (60%) in the control group had at least 1 GCS during their admission. Eleven patients (65%) in the SUDEP group and 23 patients (44%) in the control group had more than 1 GCS during their admission.
In both groups, GCS was the only seizure type associated with PGES. PGES was seen after 15 (32%) of the 47 GCS in 8 probable or definite SUDEP patients and after 40 (47%) of the 86 GCS in 22 control patients. There was no difference in the proportion of GCS with PGES in the SUDEP versus living control groups (Fisher's exact p = 0.14). PGES was a consistent finding after GCS in a minority of patients with multiple GCS captured during admission. In the SUDEP group, only 1 patient of 11 patients with multiple GCS had consistent PGES (2 GCS within 4 days) and in the control group, 5 patients of 23 patients with multiple GCS had consistent PGES (range of 2-3 GCS within 7-11 days of admission). The majority of patients had final PGES (see definition in methods section): 93% (14 of 15) in the definite or probable SUDEP group and 83% (33 of the 40) in the living controls.
We fit unadjusted and adjusted linear mixed models using PGES criteria established by Lhatoo and colleagues [9] and final PGES, which we defined in the methods section. Using criteria defined by Lhatoo and colleagues, SUDEP patients had statistically significant shorter PGES duration compared to living controls (unadjusted difference: À32.8 s, 95% CI: (À54.5, À11.2)). This association held true when adjusted for potential confounders such as number of seizures, number of days monitored and sex (adjusted difference: À39.5 s, 95% CI: (À59.4, À19.6)). When we repeated this metric using our criteria for final PGES, SUDEP status was associated with longer PGES duration than living controls, but this estimate was not statistically significant (unadjusted difference: 34.4 s, 95% CI: (À47.4, 118.3); adjusted difference: 18.1 s, 95% CI: (À63.3, 96.0)). The incidence of prolonged PGES (>50 s) was higher in living controls compared to the SUDEP group (45% vs 6%, Fisher's exact p = 0.0099).
We also fit linear mixed models to examine the effect of tonic duration and state of consciousness during seizure (sleep or wakefulness) on PGES and time to end of last PGES. Neither tonic duration nor state (sleep or wakefulness) had a statistically significant effect on the duration of PGES or final PGES.
Effect of nursing intervention
A total of 40 video of GCS seizure with PGES were reviewed in the control group, of which 2 (5%) GCS did not receive any intervention (RN stimulus, suction or O2 delivery). Twenty two (55%) of patients with GCS were suctioned and 4 (10%) GCS received oxygen. Time to earliest intervention (RN touch, suction, and oxygen) was on average 57.4 s after seizure onset (Median 52.5 s, range: 7-1516 s, SD 239 s). Earlier intervention was associated with shorter total seizure duration; there was a 0.59 s 95% CI [0.34-0.84] increase in seizure duration per second increase in time to RN intervention. Time to nursing intervention did not statistically significant effect duration of initial PGES and final PGES. We did not have the video EEG data for the SUDEP to determine the effect of nursing intervention on seizure or PGES duration.
Discussion
PGES is a frequent but inconsistent finding in patients after generalized convulsive seizures. Our results demonstrate that duration of PGES is significantly shorter in patients who die from definite or probable SUDEP compared to living controls. Our study is the first to look beyond the initial end of PGES for subsequent periods of brief suppression, which occurred in majority our patients with PGES. We found that the time from the end of the seizure to the end of last period of suppression seen on EEG was longer in patients who died than in living controls, but this estimate was not statistically significant. Earlier nursing intervention during and immediately after generalized convulsive seizures is associated with shorter total seizure duration but shortening the seizure did not affect PGES duration.
The results of our study calls into question the previously identified relevance of the PGES as a reliable marker of increased risk of SUDEP. PGES occurred in about a third to about half of our patients with GCS and rarely occurred in patients with multiple GCS during EMU stay. This, combined with our finding that the duration of PGES was shorter in patients who died from SUDEP, makes PGES an equivocal biomarker of increased risk of SUDEP.
Interestingly, we found that there was a trend for longer duration of "PGES" in the SUDEP group if the additional brief periods of suppression were factored in the total duration. To the best of our knowledge, we are not aware of any biological mechanism for PGES that would limit the defined period of suppression to immediately after a seizure. A caveat to this trend is that our review of the record was limited to the end of the clipped video EEG, which was done at about 2-3 min after the last EEG annotation by the clinician. "Clipping" is a common practice in the modern EMU control the sheer volume of video and EEG data that needs stored long-term; keeping complete long-term recording is financially prohibitive. It is possible that given a longer recording or non-clipped data, this trend may be statistically significant or conversely, not significant at all. Future studies in non-clipped video EEG files is needed to determine the significance of this trend.
In our exploratory analyses, we strived to control for variables that may influence PGES duration. The average number of seizures per patient between the two groups did not differ significantly (4.5 seizures/patient in the SUDEP vs. 4.4 seizures/patient in the living controls). Comparison of PGES was adjusted for number of days monitored, number of seizures captured and sex. There was no relationship between wakefulness and sleep on duration of PGES. Follow-up was significantly longer in patients who were living controls than those who died from SUDEP, which minimizes the possibility of SUDEP occurring in the living controls. None of our living control patients who had epilepsy surgery, which may have altered their inherent risk of SUDEP, especially if they became seizure free after surgery. We found a positive correlation between earlier nursing intervention and shorter seizure duration after a generalized convulsive seizure in the EMU, as previously reported by Seyal and Bateman [14] . Generalized seizures are associated with respiratory dysfunction such as apnea, laryngospasm and neurogenic pulmonary edema, which may result in hypoventilation, hypercapnia and hypoxemia [15] . Bateman et al. [16] measured oxygen saturations during 304 seizures in 56 patients in the EMU and found that longer seizure duration was associated with oxygen desaturation (<90%) and increased end title CO 2, a marker of hypoventilation.
The MORTEMUS study [7] , a multi-center retrospective study reviewing 16 SUDEP cases in the EMU with cardiorespiratory data all had terminal apnea followed by cardiac arrest preceding death. Earlier intervention may reduce the risk of SUDEP by shortening seizures, thereby limiting hypoventilation and desaturation [15] . Previous studies have reported that PGES is correlated with duration and severity of post-ictal hypoxemia, and that earlier nursing intervention may reverse respiratory depression sooner and therefore shorten PGES [14, 17, 18] . We did not find that periictal nursing intervention including oxygen supplementation have a statistically significant effect on the duration of initial PGES and final PGES. This inconsistency may be partially explained by the infrequent use of oxygen administration after GCS at our center (10%); the limited sample size may not have been sufficiently powered to detect a potential benefit effect of oxygen. Additionally, we did not have any video EEG, seizure medications or respiratory recording from the SUDEP patients to determine the effect of nursing intervention [13] . It's possible that patients who died from SUDEP had severe hypoxemia which was no seen in our living controls.
The fundamental difficulty in designating a specific biomarker of increased SUDEP risk is that the pathogenesis of SUDEP is poorly understood and as in the case of PGES, data is conflicting. We know from deaths occurring in the epilepsy monitoring unit (EMU) and case reports of SUDEP and near SUDEP that SUDEP may be related to a terminal generalized convulsive seizure. However, there are also reports of SUDEP cases in the EMU where a seizure did not immediately precede death [19] . Peri-ictal respiratory impairment and cardiovascular dysfunction is associated with PGES, however the exact interplay between the seizure-induced EEG suppression and failure of basic life support physiologic functions resulting in SUDEP is not known. Future prospective studies with emphasis on understanding the underlying mechanisms of SUDEP are needed to reliably identify biomarkers of increased risk to effectively develop strategies to prevent SUDEP.
